The effects of aluminium and selenium supplementation on brain and liver antioxidant status in the rat

African Journal of Biotechnology

Volumn 3, Issue 1, 2004, Pages 88-93

  Abubakar, M G ^a,b   Taylor, A ^b   Ferns, G A ^b  

^a USMANU DANFODIYO UNIVERSITY   (Nigeria)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Aluminium; Antioxidant enzymes; Brain; Liver; Rat; Selenium

Indexed keywords

ALUMINUM; ALUMINUM LACTATE; GLUTATHIONE; IRON; MALONALDEHYDE; MARKER; SELENITE; SELENIUM; SUPEROXIDE DISMUTASE;

ALUMINUM OVERLOAD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN; BRAIN LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; EXPOSURE; IN VIVO STUDY; LIPID PEROXIDATION; LIVER; LIVER LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; PROTECTION; RAT; STATISTICAL SIGNIFICANCE;

ANIMALIA;

EID: 19744379694     PISSN: 16845315     EISSN: 16845315     Source Type: Journal    
DOI: 10.5897/ajb2004.000-2016     Document Type: Article

References (52)

1. Alfrey AC, Le Gendre GR, Kaehny WD, (1976). The dialysis encephalopathy syndrome: possible aluminium intoxication. N. Engl. J. Med. 294: 184-187.
2. Alfrey AC, Hegg A, Craswell P, (1980). Metabolism and toxicity of in aluminium renal failure. Am. J. Clin. Nutr. 33(7): 1509-1516
3. Benjamins, JA, Iwata R, Hazalett J (1978). Kinetics of entry of proteins into the myelin membrane. J. Neurochem. 31: 1077-1085.
4. Bondy SC, Ali SF, Guo-Ross S (1998). Aluminum but not iron treatment induces pro-oxidant events in the rat brain. Mol. Chem. Neuropathol. 34(2-3): 219-232.
5. Candy JM, Klinowski J, Perry RH, et al. (1986). Aluminosilicates senile plaque formation in Alzheimer's disease. Lancet i: 354-357.
6. Chainy GB, Samanta L, Rout NB (1996). Effect of aluminum on superoxide dismutase, catalase and lipid peroxidation of rat liver. Res. Commun. Mol. Pathol. Pharmacol. 94(2): 217-220.
7. Campbell A, Prasad KN, Bondy SC (1999). Aluminum-induced oxidative events in cell lines: glioma are more responsive than neuroblastoma. Free Radic. Biol. Med. 26(9-10): 1166-1671.
8. Crapper McLachlan DR, DeBoni U (1980). Aluminium in human brain disease-an overview. Neurotoxicology 1: 3-16.
9. Crapper DR, Krishnan SS, Dalton AJ (1973). Brain aluminium distribution in Alzheimer's disease and especially neurofibrillary degeneration. Science 180: 511-513.
10. Crapper DR, Krishnan SS, Quittkat S (1976). Aluminium, neurofibrillary degeneration Alzheimer's disease. Brain 99(1): 67-80.
11. Deleers M (1985). Cationic atmosphere cation competition binding at negatively charged membranes: pathological implications of aluminum. Res. Commun. Chem. Pathol. Pharmacol. 49(2): 277-294.
12. Ebina Y, Okada S, Hamazaki S, Midorikawa O (1984). Liver, kidney central nervous system toxicity of aluminium given intraperitonially to rats: a multiple-dose subchronic study using aluminium nitriotriacetate. Toxicol. Appl. Pharmacol. 75: 211-218.
13. Elliot HL, Dryburgh F, Fell GS, Sabet S, Macdougall AL (1978). Aluminium toxicity durring regular hemodialysis. Br. Med. J. 1: 1101-1103.
14. Evans P (1993). Free radicals in brain metabolism and pathology. Br. Med. Bull. 49: 577-587.
15. Exley C (1999). A molecular mechanism of aluminium-induced Alzheimer's disease? J. Inorg Biochem. 76(2): 133-340.
16. Gadjusek CD, Salazar AM (1982). Amyothrophic Lateral Sclerosis and Parkinsonian Syndromes in high incidence among Avyu Japoi people of West New Guinea. Neurology. 32: 107-115.
17. Good PF, Perl DP, Bierer LM, Schmeidler J (1992). Selective accumulation of aluminum iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 31(3): 286-92.
18. Goodman Y, Steiner MR, Steiner SM, Mattson MP (1994). Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical calcium accumulation. Brain Res. 654(1): 171-176.
19. Gutteridge JM, Quinlan GJ (1983). Malondialdehyde formation from lipid peroxides in the thiobarbituric acid test: the role of lipid radicals, iron salts, and metal chelators. J. Appl. Biochem. 5(4-5): 293-299.
20. Halliwell B (1992). Reactive oxygen species the central nervous system. J. Neurochem. 59: 1609-1623.
21. Hartman PE (1983). Putative mutagens and carcinogens in foods. IV. Malonaldehyde (malondialdehyde). Environ. Mutagen. 5(4): 603-607.
22. Hirsch EC, Brandel JP, Galle P, Jvoy-Agid F, Agid Y (1991). Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease; an X-ray microanalysis. J. Neurochem. 56: 446-451.
23. Hissin PJ, Hilf R (1976). Afluorometric method for determintion of oxidised and reduced glutathione in tissues. Anal. Biochem 74: 214-226.
24. Julka D, Gill KD, (1996). Altered calcium homeostasis: a possible Mechanism of aluminium-induced neurotoxicity. Biochem. Biophys. Acta 1315: 47-54.
25. Kawahara M, Muramoto K, Kobayashi K, Mori H, Kuroda Y (1994). Aluminium promotes the aggregation of Alzheimer's amyloid β-protein in vitro. Biochem. Biophys. Res. Commun. 198: 531-535.
26. Kellett MJ, Taylor A, Oram JJ (1986). Aluminosilicates and Alzheimer's disease. Lancet i: 682.
27. Klein GL, Targoff CM, Ament ME (1980). Bone disease associated with total parenteral nutrituon. Lancet ii: 1041-1044.
28. Kuroda Y, Kobayashi K, Ichikawa M, Kawahara M, Muramoto K (1995). Application of long-term cultured neurons in aging neurological research: aluminum neurotoxicity, synaptic degeneration and Alzheimer's disease. Gerontology. 41 (Suppl 1): 2-6.
29. Leterrier JF, Langui D, Probst A, Ulrich J (1992 ). A molecular mechanism for the induction of neurofilament bundling by aluminum ions. J. Neurochem. 58(6): 2060-70.
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with folin phenol reagent. J. Biol. Chem. 193: 265-275.
31. Lukiw WJ (1997). Alzheimer's disease and aluminium. In: Yasui M, Strong, MJ, Ota K., Verity MA (Eds.), Mineral and Metal Neurotoxicology. CRC Press, New York, pp 113-126.
32. Mantyh PW, Ghilardi JR, Robers S, DeMaster EE, Allen CJ, Stimson ER, Maggio JE (1993). Aluminium, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide J. Neurochem. 61: 1171-1174.
33. Marklund SL (1976). Spectrophotometric study of spontaneous disproportionation of superoxide anion radical sensitive direct assay for superoxide dismutase. J. Biol. Chem. 251: 7504-7507.
34. Marklund SL (1985). Direct assay of superoxide dismutase with potassium superoxide. In: hand book of Methods for Oxygen Radical Research. Greenewald, R.A ed. Boca Ranto, Fla: CRC Press Inc. pp.249-255.
35. Martyn CN, Barker DJP, Osmond C, Harris EC, Edwardson JA, Lacey RF (1989). Geographical relationship between Alzheimer's disease and aluminium in drinking water. Lancet 1: 59-62.
36. McMillan TM, Freemont AJ, Herxheimer A, Denton J, Taylor AP, Pazanias M, Cummin ARC, Eastwood JB, (1993). Camelford water poisoning accident:Serial neuropscychological assessments and further observations on bone aluminium. Hum. Expt. Toxicol. 12: 37-42.
37. Meglio L, Oteiza PI (1999). Aluminum enhances melanin-induced lipid peroxidation. Neurochem. Res. 24(8): 1001-1008.
38. Moody JR, Lindstrom RM (1977). Selection and cleaning of plastic containers for stroge of trace element samples. Anal. Chem. 49: 2264-2267.
39. 2+-initiated lipid peroxidation in phospholipid liposomes by a lipophilic aluminum complex, aluminum acetylacetonate. Biochem. Biophys Acta. 1389(2): 141-149.
40. Oteiza PI, Fraga C, Keen CL (1993). Aluminum Has Both Oxidant and Antioxidant Effects in Mouse Brain Membranes. Arch.Biochem. Biophysics. 300: (1) 517-521.
41. Parkinson IS, Feest TG, Ward MK, Fawcett RWP, Kerr DNS (1979). Fracturing dialysis and osteodystrophy dialysis encephalopathy: an epidemiological survey. Lancet 1: 406.
42. Perl DP, Gajdusek DC, Garruto RM, Yanagihara RT, Gibbs Jr CJ (1982). Intraneuronal aluminium accumulation in amyotropic lateral sclerosis and Parkinson-dementia of Guam. Science 217: 1053-1055.
43. Perl DP, Brody AR (1980). X-ray spectrometric evidence of Al accumulation in neurofibrillary tangle-bearing neurones. Science 208: 297-299.
44. Rudenko SS (1999). [Selenium correction of rat liver status in disturbed antioxidant system, caused by aluminum or cadmium chlorides]. [Article in Ukrainian]. WMJ 71(3): 99-103.
45. Shike M, Harrison JE, Sturtridge WC (1980). Metabolic bone disease receiving long-term parenteral nutrition. Ann. Intern. Med. 92: 343-350.
46. Strong MJ, Garruto RM, Joshi JG, Mundy WR, Shafer TJ (1996). Can the mechanisms of aluminium neuro toxicity be integrated into a unified scheme. J. Toxicol. Environ. Health 48: 599-613.
47. Taylor A, Walker AW (1992). Measurement of aluminium in clinical samples Ann. Clin. Biochem. 29 (Pt 4): 377-389.
48. van der Voet GB, Brandsma AE, Heijink E, de Wolff FA (1992). Accumulation of aluminium in rat liver: association with constituents of the cytosol. Pharmacol Toxicol. 70(3): 173-176.
49. van Rensburg SJ, Daniels WM, Potocnik FC, van Zyl JM, Taljaard JJ, Emsley RA (1997). A new model for the pathophysiology of Alzheimer's disease. Aluminium toxicity is exacerbated by hydrogen peroxide and attenuated by an amyloid protein fragment melatonin. S Afr Med J. 87(9): 1111-1115.
50. Xie CX, St Pyrek J, Porter WH, Yokel RA (1995). Hydroxyl radical generation in rat brain is initiated by iron but not aluminum, as determined by microdialysis with salicylate trapping GC-MS analysis. Neurotoxicology. 16(3): 489-496.
51. Yoshino M, Ito M, Haneda M, Tsubouchi R, Murakami K (1999). Prooxidant action of aluminum ion-stimulation of iron-mediated lipid peroxidation by aluminum. Biometals 12(3): 237-240.
52. Zaman K (1994). Hematopoietic effects of aluminiumtoxicity. In: Nicolini, M., Zatta PF, Corain B, (Eds.). Aluminium in chemistry, Biology, and Medicine. A Series of Advances Vol. 2. (171-187pp). Harwood Academic Publishers. Switzerland.